O.P.M.S. Kratom Applauds FDA's Action on 7-OH Products
FDA also released letters to heath care professionals and consumers to educate them on the risks of these dangerous products masquerading as kratom. These documents highlight differences between natural kratom products and concentrated 7-OH products, saying '7-OH products are designed to look like everyday treats like gummies, candies, and ice cream' and 'enhanced or spiked kratom products may appear to be natural leaf, but actually contain as much as 500% more 7-OH than would be expected naturally.'
This follows a series of warning letters issued to companies illegally marketing products containing 7-OH products and was careful to clarify that its efforts were not related to kratom products with naturally occurring trace amounts of 7-OH. The Agency reassured Americans that they are not focused on scheduling or taking action against natural kratom leaf products.
We applaud this enforcement action as a critical step for consumer protection. We encourage regulatory agencies and state officials to take aggressive action to remove these products from the market and safeguard the American public. We also encourage distributors to stop selling these products immediately.
O.P.M.S. kratom products are and have always been free of harmful, synthetic alkaloids like 7-OH. Our strict manufacturing processes ensure that all O.P.M.S. products contain only natural kratom alkaloids and comply with alkaloid content and purity regulations. We will continue to support scientific, legislative, and regulatory efforts to ensure Americans have access to safe, efficacious kratom products.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
"Never Has America Been More Vulnerable" — People Are Horrified After RFK Jr. Announced He's Cutting $500 Million In Funding For mRNA Vaccines
I'm not sure if you've heard, but everyone's least favorite Health and Human Services Secretary, RFK Jr., recently announced that he's cancelling $500 million in funding for mRNA vaccine development. mRNA vaccines, which stand for messenger ribonucleic acid (RNA), are "highly effective" and "safe," according to the National Council on Aging, a nonprofit organization that works to improve the health of older adults in the US. According to the Cleveland Clinic, the mRNA vaccine helps teach your body to fight infectious diseases. More specifically, mRNA technology is utilized in the COVID-19 vaccine, which infectious disease experts say is what helped to slow the 2020 COVID-19 outbreak in the US. In a now-viral X video, RFK Jr. tried to explain the funding cuts saying, "HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses." Twitter: @SecKennedy According to CBS News, RFK Jr. reiterated that "HHS supports safe, effective vaccines for every American who wants them." Related: In response to the news, Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations, recently said, "I don't think I've seen a more dangerous decision in public health in my 50 years in the business." Following these vaccine funding cuts, millions have expressed deep concern for the future of medicine, as well as the impact of future pandemics in the US. Here's how medical professionals, lawmakers, and citizens are reacting: Commonly, people threw some personal digs at RFK Jr., with one person calling him a "despicable quack." ...and a pediatric MD calling him an "anti-vaxx weirdo." Related: While other medical professionals directly contradicted RFK Jr.'s claims about the mRNA vaccine, calling them "simply false." And called out RFK Jr.'s "fundamental misunderstanding of immunology." Another infectious disease doctor argued that RFK Jr.'s decision came from "ideology" and "online anti vax talking points." Related: And this medical professional and health writer called mRNA vaccines "one of the most important tools we have for preventing future pandemics." Another person expressed their anger about "throwing away" years of research: Even politicians have weighed in, with Senator Reverend Raphael Warnock calling the funding cuts a "tragedy." Related: "Whatever your reason for not voting or voting 3rd party, I promise it wasn't worth destroying our country over," this person wrote. And this person made a scary observation, writing: "A diseased population is easier to control..." And finally, this Reddit user summed up what many are feeling: "Imagine being so privileged to have lived in a tiny slice of human history when MILLIONS of people have been spared from pyrogens at the hands of vaccines……only to be somehow convinced the answer to the threat humanity faces going forward is to stop researching the most proven and effective medicine mankind has ever known." What are your thoughts? Let us know in the comments below. Also in In the News: Also in In the News: Also in In the News:
Business Wire
3 minutes ago
- Business Wire
BiVACOR Total Artificial Heart Accepted into FDA's Total Product Life Cycle (TAP) Program
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR, Inc., a clinical-stage medical device company developing the world's first titanium Total Artificial Heart (TAH), today announced that its TAH System has been accepted into the U.S. Food and Drug Administration's (FDA) prestigious Total Product Life Cycle (TPLC) Advisory Program, also known as the TAP program. This milestone further solidifies BiVACOR's collaboration with the FDA following the TAH's earlier recognition this year as a Breakthrough Device. This isn't just a vote of confidence in BiVACOR, it's a vote of confidence in the future of heart replacement technology. The TAP program gives us the opportunity to collaborate with the FDA at a level that aligns with urgency and magnitude of our mission. Share The TAP program is a transformative FDA initiative designed to accelerate the development and patient access to high-impact medical technologies. Entry into the program provides BiVACOR with proactive, strategic engagement with the FDA throughout the entire product life cycle, from development to commercialization, supporting more efficient, risk-informed decision-making. TAP participation is reserved for breakthrough-designated devices with the potential to significantly improve patient outcomes for serious or life-threatening conditions. 'Acceptance into the TAP program marks a major milestone not just for BiVACOR, but for the field of mechanical circulatory support as a whole,' said Daniel Timms, Founder and Chief Technology Officer of BiVACOR. 'The BiVACOR TAH has the potential to fundamentally redefine the standard of care for patients with end-stage heart failure. TAP access gives us a powerful framework for working hand-in-hand with the FDA to bring this technology to the patients who need it most.' The BiVACOR TAH is intended for use as a bridge to transplant in adults with severe, irreversible biventricular or univentricular heart failure, particularly for patients who cannot be treated with traditional left ventricular assist devices (LVADs). The system employs a magnetically levitated centrifugal pump, inspired by space and industrial technologies, which provides continuous, pulsatile, and physiologically responsive cardiac support. The FDA's acceptance letter to BiVACOR emphasized that the TAP program's inclusion reflects the agency's confidence in the technology's potential to transform clinical practice. As part of the program, BiVACOR will receive more regulatory guidance, earlier identification of scientific and evidentiary gaps, and greater coordination among stakeholders, including payers and patient advocacy groups. 'This isn't just a vote of confidence in BiVACOR, it's a vote of confidence in the future of heart replacement technology,' said William Cohn, MD, BiVACOR Chief Medical Officer and renowned cardiac surgeon. 'The TAP program gives us the opportunity to collaborate with the FDA at a level that aligns with the urgency and magnitude of our mission to bring a durable, fully implantable artificial heart to patients with no other options.' The TAP program was established as part of the FDA's efforts to modernize device development oversight and ensure the U.S. remains at the forefront of medical innovation. The program currently operates as a pilot under the Center for Devices and Radiological Health (CDRH), with acceptance based on strict criteria outlined in the Federal Register (87 FR 61605). BiVACOR's participation in TAP follows several recent milestones for the company, including its first-in-human implant as a bridge to support a patient awaiting a cardiac transplant. The company is now progressing toward expanded clinical trials in the U.S. and internationally. For more information on the FDA's TAP program, visit: Participation in the FDA's Total Product Life Cycle Advisory Program (TAP) does not imply FDA approval, clearance, or authorization. Inclusion in the TAP Pilot does not guarantee future marketing authorization or a regulatory outcome. The BiVACOR TAH is currently used as an investigational device and is not approved for commercial use. About BiVACOR BiVACOR ® is a clinical-stage medical device company developing a fully implantable, magnetically levitated Total Artificial Heart for long-term support of patients with end-stage biventricular heart failure. Founded by biomedical engineer Daniel Timms, PhD, and backed by leading experts in cardiovascular medicine including Dr. William E. Cohn and Dr. O.H. (Bud) Frazier, the company is conducting an FDA-approved Early Feasibility Study in the U.S. Headquartered in Huntington Beach, CA, with clinical operations in Houston and engineering offices in Gold Coast, Australia, BiVACOR is committed to addressing the global shortage of donor hearts through advanced, scalable technology. Learn more at
Los Angeles Times
3 minutes ago
- Los Angeles Times
Dozens killed seeking aid in Gaza as Israel weighs further military action
DEIR AL-BALAH, Gaza Strip — At least 38 Palestinians were killed overnight and into Wednesday in the Gaza Strip while seeking aid from United Nations convoys and sites run by an Israeli-backed American contractor, according to local health officials. The Israeli military said it had fired warning shots when crowds approached its forces. Another 25 people, including several women and children, were killed in Israeli airstrikes, according to local hospitals in Gaza. The military said it only targets Hamas militants. The latest deaths came as Prime Minister Benjamin Netanyahu was expected to announce further military action — and possibly plans for Israel to fully reoccupy Gaza. Experts say Israel's ongoing military offensive and blockade are already pushing the territory of some 2 million Palestinians into famine. A new U.N. report said only 1.5% of Gaza's cropland is accessible and undamaged. Another escalation of the nearly 22-month war could put the lives of countless Palestinians and around 20 living Israeli hostages at risk, and would draw fierce opposition both internationally and within Israel. Netanyahu's far-right coalition allies have long called for the war to be expanded, and for Israel to eventually take over Gaza, relocate much of its population and rebuild Jewish settlements there. President Trump, asked by a reporter Tuesday whether he supported the reoccupation of Gaza, said he wasn't aware of the 'suggestion' but that 'it's going to be pretty much up to Israel.' Of the 38 Palestinians killed while seeking aid, at least 28 died in the Morag Corridor, an Israeli military zone in southern Gaza where U.N. convoys have been repeatedly overwhelmed by looters and desperate crowds in recent days, and where witnesses say Israeli forces have repeatedly opened fire. The Israeli military said troops fired warning shots as Palestinians advanced toward them, and that it was not aware of any casualties. Nasser Hospital, which received the bodies, said another four people were killed in the Teina area, on a route leading to a site in southern Gaza run by the Israeli-backed Gaza Humanitarian Foundation, an American contractor. The Al-Awda Hospital said it received the bodies of six people killed near a GHF site in central Gaza. GHF said there were no violent incidents at or near its sites. Two of the Israeli airstrikes hit Gaza City, in the north of the territory, killing 13 people there, including six children and five women, according to the Al-Ahli Hospital, which received the bodies. The Israeli military says it only targets militants and blames civilian deaths on Hamas because its militants are entrenched in heavily populated areas. Israel facilitated the establishment of four GHF sites in May after blocking the entry of all food, medicine and other goods for 2 1/2 months. Israeli and U.S. officials said a new system was needed to prevent Hamas from siphoning off humanitarian aid. The United Nations, which has delivered aid to hundreds of distribution points across Gaza throughout the war when conditions allow, has rejected the new system, saying it forces Palestinians to travel long distances and risk their lives for food, and that it allows Israel to control who gets aid, potentially using it to advance plans for further mass displacement. The U.N. human rights office said last week that some 1,400 Palestinians have been killed seeking aid since May, mostly near GHF sites but also along U.N. convoy routes where trucks have been overwhelmed by crowds. It says nearly all were killed by Israeli fire. This week, a group of U.N. special rapporteurs and independent human rights experts called for the GHF to be disbanded, saying it is 'an utterly disturbing example of how humanitarian relief can be exploited for covert military and geopolitical agendas in serious breach of international law.' The experts work with the U.N. but do not represent the world body. The GHF did not immediately respond to a request for comment. The Israeli military says it has only fired warning shots when crowds threatened its forces, and GHF says its armed contractors have only used pepper spray and fired into the air on some occasions to prevent deadly crowding at its sites. Israel's air and ground war has destroyed nearly all of Gaza's food production capabilities, leaving its people reliant on international aid. A new report by the U.N.'s Food and Agriculture Organization and the U.N. satellite center found that just 8.6% of Gaza's cropland is still accessible following sweeping Israeli evacuation orders in recent months. Just 1.5% is accessible and undamaged, it said. The military offensive and a breakdown in security have made it nearly impossible for anyone to safely deliver aid, and aid groups say recent Israeli measures to facilitate more assistance are far from sufficient. Hospitals recorded four more malnutrition-related deaths over the last 24 hours, bringing the total to 193 people, including 96 children, since the war began in October 2023, according to the Gaza Health Ministry. Jordan said Israeli settlers blocked roads and hurled stones at a convoy of four trucks carrying aid bound for Gaza after they drove across the border into the Israeli-occupied West Bank. Israeli far-right activists have repeatedly sought to halt aid from entering Gaza. Jordanian government spokesperson Mohammed al-Momani condemned the attack, which he said had shattered the windshields of the trucks, according to the Jordanian state-run Petra News Agency. The Israeli military said security forces went to the scene to disperse the gathering and accompanied the trucks to their destination. Hamas-led militants killed some 1,200 people, mostly civilians, in the Oct. 7, 2023, attack and abducted another 251. Most of the hostages have been released in ceasefires or other deals. Of the 50 still held in Gaza, around 20 are believed to be alive. Israel's retaliatory offensive has killed over 61,000 Palestinians, according to Gaza's Health Ministry, which does not say how many were fighters or civilians but says around half were women and children. It is part of the now largely defunct Hamas-run government and staffed by medical professionals. The U.N. and independent experts consider it the most reliable source for the number of war casualties. Shurafa, Khaled and Melzer write for the Associated Press. Khaled reported from Cairo and Melzer from Tel Aviv. Israel. Associated Press writers Stefanie Dazio in Berlin and Sally Abou AlJoud in Beirut contributed to this report.
